» Authors » Linda A DiMeglio

Linda A DiMeglio

Explore the profile of Linda A DiMeglio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 217
Citations 8697
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetes Care . 2024 Jun; 47(8):1276-1298. PMID: 38912694
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease...
12.
Phillip M, Achenbach P, Addala A, Albanese-ONeill A, Battelino T, Bell K, et al.
Diabetologia . 2024 Jun; 67(9):1731-1759. PMID: 38910151
Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease...
13.
Ekhlaspour L, Buckingham B, Bauza C, Clements M, Forlenza G, Neyman A, et al.
J Clin Transl Endocrinol . 2024 Jun; 36:100352. PMID: 38860154
Objectives: To report the safety and side effects associated with taking verapamil for beta-cell preservation in children with newly-diagnosed T1D. Research Design And Methods: Eighty-eight participants aged 8.5 to 17.9 ...
14.
Purswani M, Jacobson D, DiMeglio L, Yao T, Kopp J, Van Dyke R, et al.
J Pediatric Infect Dis Soc . 2024 May; 13(8):396-405. PMID: 38820092
Background: Tenofovir disoproxil fumarate (TDF) is often used in treating pregnant women living with HIV. Third-trimester TDF exposure is associated with a 12% reduction in bone mineral content in HIV-exposed...
15.
Ismail H, Liu J, Netherland Jr M, Evans-Molina C, DiMeglio L
medRxiv . 2024 May; PMID: 38798462
Acetylated and butyrylated high amylose starch (HAMS-AB) is a prebiotic shown to be effective in type 1 diabetes (T1D) prevention in mouse models and is safe in adults with established...
16.
Levy C, Bailey R, Laffel L, Forlenza G, DiMeglio L, Hughes M, et al.
Diabetes Technol Ther . 2024 May; 26(9):652-660. PMID: 38696672
To evaluate the safety and explore the efficacy of use of ultra-rapid lispro (URLi, Lyumjev) insulin in the Tandem t:slim X2 insulin pump with Control-IQ 1.5 technology in children, teenagers,...
17.
Galderisi A, Marks B, DiMeglio L, de Beaufort C
Lancet Diabetes Endocrinol . 2024 Apr; 12(5):297-299. PMID: 38663944
No abstract available.
18.
Mehta S, Ryabets-Lienhard A, Patel N, Breidbart E, Libman I, Haller M, et al.
Horm Res Paediatr . 2024 Apr; :1-12. PMID: 38663372
Teplizumab (TzieldTM, Provention Bio), a monoclonal antibody directed at T-cell marker CD3, is the first medication approved by the FDA to delay progression from stage 2 to stage 3 type...
19.
Felton J, Redondo M, Oram R, Speake C, Long S, Onengut-Gumuscu S, et al.
Commun Med (Lond) . 2024 Apr; 4(1):66. PMID: 38582818
Background: Islet autoantibodies form the foundation for type 1 diabetes (T1D) diagnosis and staging, but heterogeneity exists in T1D development and presentation. We hypothesized that autoantibodies can identify heterogeneity before,...
20.
Fox D, Ware J, Boughton C, Allen J, Wilinska M, Tauschmann M, et al.
J Diabetes Sci Technol . 2024 Mar; :19322968241231950. PMID: 38494876
Background/objective: The main objective of this study is to evaluate the incremental cost-effectiveness (ICER) of the Cambridge hybrid closed-loop automated insulin delivery (AID) algorithm versus usual care for children and...